Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD of Can-Fite BioPharma Ltd. from Q4 2023 to Q4 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
-
Summary
-
Can-Fite BioPharma Ltd. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and change rate from Q4 2023 to Q4 2024.
- Can-Fite BioPharma Ltd. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 31 Dec 2024 was $29K, a 1350% increase year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)